ArticleCureus2026
Plantar Verrucous Carcinoma Misdiagnosed as a Recalcitrant Wart: Diagnostic Pitfalls and Destructive Local Progression.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic plantar verrucous lesions represent a frequent diagnostic challenge, as they often mimic benign conditions such as plantar warts. However, the continued assumption of a benign diagnosis despite lack of therapeutic response reflects not only delayed biopsy, but also insufficient consideration of relevant differential diagnoses, including cutaneous malignancies and deep infections. Among these, verrucous carcinoma, particularly its plantar variant, carcinoma cuniculatum, is a rare but locally aggressive subtype of cutaneous squamous cell carcinoma characterized by slow growth, low metastatic potential, and progressive local destruction. We report the case of a 76-year-old male with an 8-year history of a verrucous lesion on the right foot, demonstrating progressive enlargement and initially managed as an infectious and inflammatory condition with multiple topical and systemic therapies, without clinical improvement. Over time, the lesion evolved into a large exophytic mass with ulceration, malodorous discharge, and significant functional limitation. Imaging studies revealed suspicious inguinal lymphadenopathy without confirmed distant metastasis. A deep incisional biopsy established the diagnosis of well-differentiated squamous cell carcinoma, verrucous variant (carcinoma cuniculatum). Due to extensive locoregional involvement and a high risk of functional morbidity, the tumor was deemed initially unresectable. Systemic treatment with pembrolizumab (200 mg every three weeks) was initiated in the setting of locally advanced unresectable disease. After six cycles, the patient demonstrated a partial clinical and radiological response, with sustained disease control and good tolerance after eleven cycles, allowing reassessment for potential surgical management. This case illustrates how prolonged diagnostic delay, in this instance, nearly eight years, can lead to locally advanced disease, limiting initial surgical options. It underscores the importance of early biopsy and comprehensive diagnostic reassessment in chronic verrucous lesions, as well as the potential role of immunotherapy as a therapeutic alternative in selected patients with advanced verrucous carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.